Pancreatic Cancer Clinical Trials in Milwaukee, Wisconsin

6 studies are recruiting for pancreatic cancer in Milwaukee, Wisconsin right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)

   The purpose of this study is to evaluate the safety and efficacy of a novel RAS(ON) inhibitor compared to standard of care (SOC) observation only.

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Froedtert Hospital and the Medical College of Wisconsin, Milwaukee, Wisconsin

   Locations

   74 in total

   Run by

   Revolution Medicines, Inc.

   See if you can join NCT07252232 on ClinicalTrials.gov

2. Pancreatic Cancer Detection Consortium

   This study aims to prospective validate an exosome-based miRNA signature for noninvasive and early detection of pancreatic ductal adenocarcinoma.

   Stage

   Not phased

   Ages

   18 and older

   Site

   Medical College of Wisconsin, Milwaukee, Wisconsin

   Locations

   11 in total

   Run by

   City of Hope Medical Center

   See if you can join NCT06388967 on ClinicalTrials.gov

3. The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study

   The Multi-OutcoMe EvaluatioN of radiation Therapy Using the Unity MR-Linac Study (MOMENTUM) is a multi-institutional, international registry facilitating evidenced based implementation of the Unity MR-Linac technology and further technical development of the MR-Linac system with the ultimate purpos…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Medical College of Wisconsin, Milwaukee, Wisconsin

   Locations

   18 in total

   Run by

   UMC Utrecht

   See if you can join NCT04075305 on ClinicalTrials.gov

4. PurIST Classification-Guided Adaptive Neoadjuvant Chemotherapy by RNA Expression Profiling of EUS Aspiration Samples

   This is an open-label, phase II study in patients with resectable and borderline resectable pancreatic cancer.

   Stage

   Phase 2

   Ages

   18 and older

   Site

   Froedtert & the Medical College of Wisconsin, Milwaukee, Wisconsin

   Locations

   2 in total

   Run by

   Medical College of Wisconsin

   See if you can join NCT04683315 on ClinicalTrials.gov

5. Pancreatic Cancer Adaptive Neoadjuvant Chemotherapy Trial

   This is an open-label, phase II study in patients with resectable and borderline resectable pancreas cancer.

   Stage

   Phase 2

   Ages

   18 and older

   Site

   Froedtert & the Medical College of Wisconsin, Milwaukee, Wisconsin

   Run by

   Medical College of Wisconsin

   See if you can join NCT03322995 on ClinicalTrials.gov

6. Chemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic Adenocarcinoma

   The purpose of this study is to determine if combination treatment with cemiplimab, motixafortide, gemcitabine, and nab-paclitaxel is effective in decreasing the size of the tumor(s), if it will prolong life in patients, and if it's safe. The treatment consists of standard chemotherapy (gemcitabine…

   Stage

   Phase 2

   Ages

   18 and older

   Site

   Medical College of Wisconsin, Wisconsin Diagnostic Labratories, Milwaukee, Wisconsin

   Locations

   3 in total

   Run by

   Gulam Manji

   See if you can join NCT04543071 on ClinicalTrials.gov